Why Adults Over 60 Are Choosing Cannabis Edibles Over Prescription Pills

The Fastest-Growing Cannabis Demographic

They are not stereotypical stoners. They are retirees, grandparents, and professionals in their sixties and seventies who have decided, often after decades of abstinence or no prior use at all, to walk into a dispensary and buy cannabis for the first time. Adults over 60 represent the fastest-growing demographic in legal cannabis markets, and a new study published in JAMA Network Open reveals what is driving them through those doors.

Researchers from the University of Utah Health and the University of Colorado Boulder interviewed 169 adults over 60 who were about to purchase cannabis for the first time. Their motivations were remarkably consistent: 57 percent were seeking help with sleep, 50 percent with pain, and 25 percent with mental health concerns. These are people who have often tried conventional pharmaceutical approaches and found them inadequate, laden with side effects, or simply not working.

The Goldilocks Product

One of the study's more revealing findings was about product choice. When given the range of options available at a modern dispensary — THC-dominant products, CBD-only products, or combination formulations — the majority of first-time buyers over 60 chose products containing both THC and CBD.

The researchers described this as the "Goldilocks option." Older adults perceived combination products as offering the therapeutic benefits they were seeking without the intensity of high-THC products or the perceived inadequacy of CBD alone. They wanted something in the middle, and the market has responded with a growing array of balanced-ratio edibles, tinctures, and capsules designed for exactly this consumer.

Edibles, in particular, have become the preferred format for older adults. They do not require inhalation, which many seniors want to avoid due to respiratory concerns. They offer precise dosing, especially in the low-dose formats (2.5 to 5 milligrams of THC per serving) that have become widely available. And they are discreet, carrying none of the social stigma associated with smoking.

Word of Mouth Over Medical Advice

Perhaps the most concerning finding in the study was how these first-time buyers were making their purchasing decisions. The majority reported that their choices were influenced primarily by word of mouth — recommendations from friends, family members, or fellow consumers — rather than by discussions with healthcare providers.

This is a significant gap. Older adults are more likely than younger consumers to be taking multiple prescription medications, many of which can interact with cannabinoids. Cannabis can affect the metabolism of blood thinners, certain heart medications, and some psychiatric drugs. Without guidance from a physician or pharmacist who understands both cannabis pharmacology and the patient's medication regimen, there is a real risk of adverse interactions.

The reluctance of older adults to discuss cannabis with their doctors reflects a broader problem in the healthcare system. Many physicians lack training in cannabinoid medicine and feel uncomfortable making recommendations. Some patients fear judgment or worry that disclosing cannabis use could affect their medical care. The result is a population making medical decisions without medical guidance.

What Is Driving the Trend

Several converging factors explain why older adults are turning to cannabis in growing numbers. The opioid crisis has made both patients and physicians more cautious about prescription painkillers. Many older adults have direct experience with the risks of long-term opioid use, either personally or through family members, and are actively seeking alternatives.

Sleep medications carry their own risks for older adults, including increased fall risk, cognitive impairment, and dependence. Cannabis, particularly low-dose edibles with balanced THC-to-CBD ratios, is perceived as a gentler alternative, though long-term data on its safety in this population remain limited.

The normalization of cannabis through legalization has also played a role. As dispensaries have become as common as pharmacies in many communities, the stigma associated with purchasing cannabis has diminished, particularly for medical use. Older adults who would never have visited a dispensary five years ago now see it as a reasonable option.

The Products Meeting This Demand

The cannabis industry has taken notice of the senior demographic and is developing products specifically tailored to their needs. Low-dose edibles in formats like lozenges, soft chews, and dissolvable tablets are proliferating. Topical products designed for joint pain and inflammation are prominently displayed in dispensaries. Tinctures with calibrated droppers allow precise, incremental dosing.

Some dispensaries have introduced senior-specific shopping hours, educational events, and consultation services staffed by pharmacists or nurses. A handful of brands have launched product lines marketed explicitly to older adults, with packaging that emphasizes medical-grade quality and clear dosing information.

The Research That Still Needs to Happen

While the University of Utah study provides valuable insight into why seniors are choosing cannabis, it also underscores how much remains unknown about cannabis use in this age group. Long-term studies on the safety and efficacy of cannabis for sleep and chronic pain in older adults are scarce. Most clinical trials exclude participants over 65, leaving a significant evidence gap.

Questions about optimal dosing, product formulation, and the long-term effects of regular cannabis use on aging bodies remain unanswered. As the population of older cannabis users grows, the urgency of filling these gaps intensifies.

For now, the trend is clear: older adults are voting with their wallets, choosing cannabis edibles as an alternative to the pharmaceutical options they have found wanting. Whether the medical establishment and the research community can catch up to meet their needs remains an open question.

Find verified shops in your state through Budpedia's cannabis dispensary directory.